Dear Reader,
As we reach the final issue of Drugs in R&D for 2018, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.
2018 was a successful year for Drugs in R&D. Over 30 articles have been published; the most popular of these, in terms of downloads from SpringerLink, have been:
Rodrígues-Portal J.A. Efficacy and Safety of Nintedanib for the Treatment of Idiopathic pulmonary fibrosis: An update.
Auffret M, Drapier S, Vérin M. The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.
Buoli, M, Serati, M, Botturi A, Altamura AC. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
Guitart J, Vargas MI, De Sanctis V, Folch J, Salazar R, Fuentes J, Coma J, Ferreras J, Moya J, Tomás A, Estivill P, Rodelas F, Jiménez AJ, Sanz A. Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
Piwnica D, Pathak A, Schäfer, Docherty JR. In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea.
Liebl A, Mohan V, Yang W, Krzysztof S, Linjawi S. 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes.
Garimella T, Tao, X, Sims K, Yi-Ting C, Rana J, Myers E, Wind-Rotolo M, Bhatnagar R, Eley T, LaCreta F, AbuTarif M. Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects.
Solowij N, Galettis P, Broyd SJ, de Krey P, Martin JH. Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to Patients in a Hospital Setting.
López-Cedrún J, Videla S, Burgueño M, Juárez I, Aboul-Hosn S, Martín-Granizo R, Grau J, Puche M, Gil-Diez J, Hueto JA, Vaqué A, Sust M, Plata-Salamán C, Monner A. Co-crystal of Tramadol–Celecoxib in Patients with Moderate to Severe Acute Post-surgical Oral Pain: A Dose-finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre, Phase II Trial.
Chen JJ, Hewitt LA. Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects.
The quality of articles published in the journal is also reflected in its most recent Citescore (2.3). Based on this Citescore Drugs in R&D is ranked 125th among 329 journals in the ‘Pharmacology’ Category.
Other journals in the Adis Premier Journals Portfolio (http://www.springer.com/gp/adis) continue to prosper with substantial increases in usage year on year. In addition, this year has seen Applied Health Economics and Health Policy receive its first impact factor.
We thank the authors who have contributed articles to Drugs in R&D over the course of 2018. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Drugs in R&D in the last 12 months:
Mohd Hafiz Abdul Aziz, Australia
Guohua An, USA
Emmanuel Bäckryd, Sweden
Edward Bastyr, USA
Hannah K. Batchelor, UK
Ahmad Beydoun, Lebanon
Rodolfo Eduardo Bordoni, USA
Arjan Bredenoord, The Netherlands
Döndü Cansu, Turkey
Brett J. Carroll, USA
Noel C. Chan, Canada
Pier Giorgio Cojutti, Italy
Adam Collison, Australia
Ranjeet Prasad Dash, USA
Fernando Augusto de Lima Marson, Brazil
Renato De Vecchis, Italy
David Devos, France
Makoto Endo, Japan
Linda Felton, USA
Gloria Formoso, Italy
Raffaele Giusti, Italy
Steven Greenway, Canada
Thomas Greuter, USA
Christian Höcht, Argentina
Rebecca L. Hartman, USA
Simon Hill, UK
Zhe Hui Hoo, UK
Florenzo Iannone, Italy
Yoshihiko Kanno, Japan
Jothydev Kesavadev, India
Abhilash Koratala, USA
Dirk Kropeit, Germany
Rutuja Kulkarni, USA
Stuart Lieblich, USA
Wei Liu, USA
Lukas Lofling, Sweden
Vincent Maida, Canada
Francisco Marin, Spain
Sean McAllister, USA
Janthima Methaneethorn, Thailand
Giuseppe Micali, Italy
Pawel Mierzejewski, Poland
Andrew R. A. Moore, UK
Hiroshi Nagayama, Japan
Cade Nylund, USA
Onur Ozturk, Turkey
Manjunath P. Pai, USA
Rosa Maria Paragliola, Italy
Deven Parmar, India
Nupur Patel, USA
Nitipong Pempalung, USA
Santiago Perez-Lloret, Argentina
Goran Petrovski, Republic of North Macedonia
Cameron Phillips, Australia
Birk Poller, Switzerland
Ronald Reed, USA
Bernhard Resch, Austria
Hanno B. Riess, Germany
Antonio A. Rossi, Italy
Makoto Saito, UK
Cristina Sanches, Brazil
Helmut Schütz, Austria
Jan-Frederik Schlender, Germany
Alec Schmaier, USA
Ravi Shankar, USA
Joanne Louise Sharp, UK
Jordan Smith, USA
Konstantina Soulele, Greece
Edyta Szalek, Poland
Konstantinos Thomas, Greece
Nataliya Titova, The Russian Federation
Laszlo Tothfalusi, Hungary
Teresa Christina Gomes Alfinito Vieira, Brazil
Hiroki Wakabayashi, Japan
Thomas J. Walsh, USA
Eric Wenzler, USA
Yuichi Yoshida, Japan
In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
G. An, University of Iowa, Iowa, IA, USA
R. K. Campbell, Washington State University, Pullman, WA, USA
D. Cattaneo, Luigi Sacco University Hospital, Milan, Italy
G. Cherala, Eastern Virginia Medical School, Norfolk, VA, USA
R. P. Dash, Johns Hopkins School of Medicine, Baltimore, MD, USA
Y.K. Gupta, All India Institute of Medical Sciences, New Delhi, India
H. P. Hartung, Heinrich-Heine University, Dusseldorf, Germany
C. Höcht, University of Buenos Aires, Buenos Aires, Agentina
N. M. Idkaidek, University of Petra, Amman, Jordan
F. Jamali, University of Alberta, Edmonton, AB, Canada
T. K. L. Kiang, The University of British Columbia, Vancouver, BC, Canada
M. J. McKeage, University of Auckland, Auckland, New Zealand
P. J. Nathan, Monash University, Melbourne, VIC, Australia
B. M. Patel, Nirma University, Ahmedabad, India
S. Perez-Lloret, Institute for Cardiology Research, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina
M. Pfister, University of Basel, Basel, Switzerland
G. Remington, University of Toronto, Toronto, ON, Canada
H. Schütz, BEBAC Consulting, Vienna, Austria
M. H. Shishehbor, Cleveland Clinic Cardiovascular Disease, Cleveland, OH, USA
L. P. Shulman, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA
L. Tóthfalusi, Semmelweis University, Budapest, Hungary
J. Weiss, University of Heidelberg, Heidelberg, Germany
We do hope that you have found the articles published throughout the year in Drugs in R&D to be interesting and informative. The editorial schedule for 2019 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.
With best wishes,
Anton van Rensburg
Editor,
Drugs in R&D
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Drugs R D 18, 251–253 (2018). https://doi.org/10.1007/s40268-018-0252-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40268-018-0252-x